On average, patients on Zepbound or Wegovy lose between 14% and 20% of their initial body weight over 72 weeks
In those places, the drug is actually widening the gap, she said
The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke
Millions of people are taking weight loss medications across the UK, but this evidence shows the risks of ignoring strength training and exercise during treatment, says Dr Matthew Wade, Interim Director of Research at ukactive
Toxicity appears quite low
A recent analysis using Mendelian randomization showed that genetically predicted homocysteine levels increased the odds of NAFLD.[ref] Related article: NAFLD genes Cardiovascular disease: To answer the question of whether a modestly elevated homocysteine level is causally associated with an increased risk of cardiovascular disease, researchers again used huge genetic data sets and Mendelian randomization to determine causality
